Clinical Trials Browser

Phase 3 × INDUSTRY × secukinumab × Clear all

NCT01961609 2019-03-18

SIGNATURE

Phase 3 Completed

235 enrolled 23 charts

Psoriasis

NCT02911857 2018-08-20

An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes

Phase 3 Completed

4 enrolled 7 charts

Periodic Fevers Syndrome

NCT01350804 2016-05-23

NURTURE 1

Phase 3 Completed

551 enrolled 19 charts

Arthritis, Rheumatoid